The American Society for Addiction Medicine (ASAM), American Psychiatric Association (APA), National Institute on Drug Abuse (NIDA) and Friends Research Institute (FRI) are developing the Addiction Medicine Practice-based Research Network (AMNet) to address the nation's opioid epidemic.
Though addiction medicine/psychiatry practices play an essential role in responding to the opioid epidemic, little is known about the type of patients treated in these practices, the type and quality of services their patients receive, and their patient outcomes. These practices often have limited opportunities to organize their data for quality improvement (QI) efforts and are rarely invited to participate in clinical research. AMNet aims to change this disparity.
On December 18, a special information and session on AMNet will be held virtually to introduce participants to the background and aims of AMNet, discuss eligibility criteria and advantages of participating in AMNet, and demonstrate how to access AMNet standardized tools and quality measures in the PsychPRO.
AMNet Informational Session
Friday, December 18, 2020
2:00 pm CST / 3:00 pm EST
Please register in advance
Questions may be directed to AMNet@psych.org